Disease-Modifying Approach to the Treatment of Alzheimer's Disease: From α-Secretase Activators to γ-Secretase Inhibitors and Modulators

By Panza Francesco  

Drugs & Aging, Vol. 26, Iss. 7, 2009-07 ,pp. : 537-555

Adis International

Access to resources Recommend Favorite

&ggr;-Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease: Disappointments and Hopes

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 12, 2011-06 ,pp. : 1555-1570

Bentham Science Publishers

Access to resources Recommend Favorite

Views on Amyloid Hypothesis and Secretase Inhibitors for Treating Alzheimer's Disease: Progress and Problems

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4295-4312

Bentham Science Publishers

Access to resources Recommend Favorite

Human β-secretase and Alzheimer’s disease

By Citron Martin  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 3, 2001-06 ,pp. : 341-348

Informa Healthcare

Access to resources Recommend Favorite

Editorial [Hot Topic:Gamma-Secretase Inhibitors and Modulators as a Therapeutic Approach to Alzheimers disease (Guest Editor: Bruno P. Imbimbo)]

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 1, 2008-01 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite